Kourosh Rezania, MD
Enriched profileProfessor of Neurology; Neuromuscular Medicine Section Chief; Director, Neuromuscular Medicine Fellowship Program; Director, ALS Multidisciplinary Clinic · University of Chicago
Kourosh Rezania is Professor of Neurology; Neuromuscular Medicine Section Chief; Director, Neuromuscular Medicine Fellowship Program; Director, ALS Multidisciplinary Clinic at University of Chicago. OpenAlex indexes 169 publications with 2,598 citations (h-index 23); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 8 Oct 2026
Overview
Updated 15 Oct 2026
Kourosh Rezania is Professor of Neurology at University of Chicago. The public record shows 169 publications with 2,598 citations (h-index 23), centered on Peripheral Neuropathies and Disorders, Pancreatic function and diabetes, Amyotrophic Lateral Sclerosis Research. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 14 companies, 1 NIH-funded awards (2021–2025).
- Most recent indexed publication: 2026 · Neurology
- Top research focus: Peripheral Neuropathies and Disorders
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 14 companies
Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 7 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 36.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 15 Oct 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Intermuscular Coherence as a Biomarker for ALS
Sponsor: University of Chicago
- The Significance of Glucose Intolerance in the Pathogenesis of Idiopathic Axonal Polyneuropathy
Sponsor: University of Chicago
Industry payments
Updated 15 Oct 2026
14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year202520 payments$28,659openpaymentsdata.cms.gov ↗
- Alexion Pharmaceuticals, Inc.Program year202512 payments$11,615openpaymentsdata.cms.gov ↗
- Grifols USA, LLCProgram year20254 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
58.8%Gabapentinoids20.9%Gabapentin62%Pregabalin38%Part D≥54 patientsSNRI12.9%Duloxetine Hcl100%Part D≥48 patients+ 8 more classes in this area
Respiratory
16%Opioid Agonist14.3%Hydrocodone-Acetaminophen100%Part D≥38 patientsCatecholamine1%Epinephrine100%Part D≥13 patients+ 1 more class in this area
Musculoskeletal
6.8%gamma-Aminobutyric Acid-ergic Agonist3.1%Baclofen100%Part D≥13 patientsMuscle Relaxant2.4%Cyclobenzaprine Hcl50%Carisoprodol50%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 15 Oct 2026
1 NIH research award on record, funded 2021–2025 per NIH RePORTER. The latest:
- Intermuscular coherence: A novel biomarker for upper motor neuron dysfunction in ALS
University of Chicago
FY2025$538,546R01NS116262 - Intermuscular coherence: A novel biomarker for upper motor neuron dysfunction in ALS
University of Chicago
FY2024$580,434R01NS116262 - Intermuscular coherence: A novel biomarker for upper motor neuron dysfunction in ALS
University of Chicago
FY2023$598,384R01NS116262
Publications
Updated 15 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Peri-operative Reparixin therapy resulted in 50% 5-year insulin independence rate: The University of Chicago experience.
Clinical transplantation
Letter2023 - Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations.
Journal of clinical medicine
Review2021
Most-cited works
by citation count (OpenAlex)- 01Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical ManifestationsArticle479 citations2021
- 02A clinical trial of creatine in ALSArticle294 citations2004
- 03
- 04Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase IIIArticle237 citations2009
- 05Current Treatment of Myasthenia GravisArticle152 citations2022
Network
Updated 15 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 15 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Tehran University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurology.uchicago.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchicagomedicine.org ↗
Editorial & leadership roles
journal and society appointments- Member
American Academy of Neurology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchicagomedicine.org ↗ - Member
American Association of Neuromuscular and Electrodiagnostic Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchicagomedicine.org ↗ - Member
American Association for the Advancement of Science
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchicagomedicine.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Everett Vokes, MD
University of Chicago
Ralph Weichselbaum, MD
University of Chicago
Mary Rinella, MD
University of Chicago
Hedy Kindler, MD
University of Chicago
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH